Talaviya PA, Vyas BM, Indoria SP, Modh VB. Review on special emphasis of bortezomib on relapsed/refractory myeloma. Int J Res Med Sci [Internet]. 2017 Jan. 26 [cited 2025 Oct. 30];2(4):1278-82. Available from: https://www.msjonline.org/index.php/ijrms/article/view/2408